VITROS CHEMISTRY PRODUCTS TOBRA REAGENT 6801712

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-02-14 for VITROS CHEMISTRY PRODUCTS TOBRA REAGENT 6801712 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[139090069] The investigation concluded that higher than expected vitros tobramycin (tobra) results were obtained from a high level calibrator fluid processed using a vitros 5600 integrated system. A definitive root cause could not be determined. The calibrator fluid was diluted and tested as part of an investigation for an issue with high diluted tobra results on multiple cap proficiencies. The higher than expected results for diluted samples have occurred across multiple vitros tobra lots of reagent over time. Ongoing tracking and trending of complaints has not identified any signals that would suggest there is a systemic issue with vitros tobra reagent lot 1513-03-5038. The assignable cause is not likely to be related to a specific reagent lot or calibration event. An instrument issue or an issue related to the on-board dilution cannot be ruled out as a contributing factor.
Patient Sequence No: 1, Text Type: N, H10


[139090070] A customer obtained higher than expected vitros tobramycin (tobra) results from a high level calibrator fluid processed using a vitros 5600 integrated system. Calibrator kit lot 1428, bottle 6 results 14. 0, 14. 3 ug/ml versus an expected result of 10. 4, 10. 6 ug/ml. No erroneous patient sample results were obtained or reported from the laboratory. However, the investigation cannot definitively conclude that patient sample results were not affected or would not be affected if the event were to recur undetected. There was no allegation of actual patient harm as a result of this event. This report corresponds to ortho clinical diagnostics inc (ortho). Complaint numbers (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319808-2019-00006
MDR Report Key8339392
Date Received2019-02-14
Date of Report2019-02-14
Date of Event2019-01-16
Date Mfgr Received2019-01-18
Device Manufacturer Date2018-05-17
Date Added to Maude2019-02-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street1000 LEE ROAD
Manufacturer CityROCHESTER NY 14606
Manufacturer CountryUS
Manufacturer Postal Code14606
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS TOBRA REAGENT
Generic NameIN-VITRO DIAGNOSTIC
Product CodeLDO
Date Received2019-02-14
Catalog Number6801712
Lot Number1513-05-6924
Device Expiration Date2019-11-17
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2019-02-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.